MENU
TCON
Stock ticker: OTC
PRICE
CHANGE
CAPITALIZATION

TRACON Pharmaceuticals (TCON) Ownership - Who owns TRACON Pharmaceuticals?

TRACON Pharmaceuticals Inc is a biopharmaceutical company focused on the development and commercialization of novel targeted therapeutics for cancer and utilizing its cost efficient, contract research organization (CRO) independent product development platform to partner with ex-U... Show more

Industry: #Biotechnology

Profile

Industry
Biotechnology
Address
N/A
Phone
N/A
Employees
N/A
Web
N/A

Details

Group
Domestic Stock Funds
Category
Biotechnology
Capitalization
2.28M
P/E Ratio
0.01
Total Cash
7.89M
Projected Growth
N/A
Total Debt
236K
Revenue
12.15M
Risk (Beta)
0.90
Dividend Yield
N/A
Total Cash/Share
2.95
Total Debt/Equity
N/A
Revenue/Share
7.35 USD as % of share price
Who owns TRACON Pharmaceuticals? TCON symbol Ownership - Tickeron.com